ClearPoint Neuro, Inc. planned insider sales
In the last twelve months insiders at ClearPoint Neuro, Inc. filed 11 Form 144 notices of planned sales, 1.1 million shares worth $17.8 million at the time of filing, from 8 sellers. The latest, filed 29 June 2026: Joseph Burnett (director, officer), 20,000 shares worth $369,600, planned for around 29 June 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 29 June 2026 | Joseph Burnett | Director, Officer | 20,000 | $369,600 | 29 June 2026 | 20,000 shares from 29 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 17 June 2026 | Joseph M Burnett Trust | Affiliate of Director | 1,843 | $24,586 | 17 June 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Previously vested RSU | Form 144 |
| 17 June 2026 | Joseph Burnett | Director, Officer | 60,000 | $800,400 | 17 June 2026 | 61,843 shares from 17 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 1 June 2026 | Timothy Richards | Director | 5,145 | $62,612 | 1 June 2026 | 5,415 shares from 1 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted stock vesting under a registered plan | Form 144 |
| 29 May 2026 | Pascal E. Girin | Director | 66,679 | $836,455 | 29 May 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 21 May 2026 | Matthew B Klein | Director | 16,000 | $185,392 | 21 May 2026 | 16,000 shares from 21 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted stock vesting under a registered plan | Form 144 |
| 20 May 2026 | Lynnette C Fallon | Director | 5,091 | $56,866 | 20 May 2026 | 5,091 shares from 20 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 25 February 2026 | Joseph M Burnett Trust | Affiliate of Director | 21,794 | $317,103 | 25 February 2026 | 19,951 shares from 25 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Previously vested RSA; Previously vested RSU | Form 144 |
| 26 January 2026 | Joseph M Burnett Trust | Affiliate of Director | 2,943 | $46,146 | 26 January 2026 | 2,943 shares from 26 January 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 9 January 2026 | Joseph M Burnett | Director, Officer | 20,000 | $306,200 | 9 January 2026 | 20,000 shares from 9 January 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 12 November 2025 | PTC Therapeutics, Inc. | Affiliate of director | 894,578 | $14.8 million | 12 November 2025 | No matching Form 4 sale | Cantor Fitzgerald & Co. | Private placement; Public offering | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.